UNLOCKING LEGALITIES: Challenges And Surprises In The EU Medtech Reg Reform
This article was originally published in SRA
Executive Summary
The texts of the new EU medical device and IVD regulations have now been published in their likely final versions, save for the tweaking expected during the European Commission's legal review. Scrip Regulatory Affairs sister publication Clinica asked Erik Vollebregt, partner at Axon Lawyers, what the most significant challenges will be now for the whole of the medtech sector, and where the biggest surprises lie.
You may also be interested in...
EU TTIP Device Proposals Rely Heavily on Device Regulators Forum
The European Commission circulated its device-regulation proposals as part of negotiations for the Transatlantic Trade and Investment Partnership with the US. It emphasized convergence of technical and clinical requirements and the important role of the International Medical Device Regulators Forum.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.